A New Era in Therapy
66% of blindness in Europe and the US is caused by retinal diseases - and thus preventable.
deepeye empowers the field of ophthalmology with AI-driven optimal therapy planning support, enabling additional insights into treatment data of patients suffering from retinal eye diseases. These conditions such as Age-related Macular Degeneration (AMD) are prevalent in over 12% of the European and US population, causing more than 66% of cases of blindness. Through our precision medicine platform, we aim to address the root causes of these vision impairments.
What Sets Us Apart
The Digital Therapy Assistant
At deepeye, we’re pioneering a shift in retinal therapy through our specialized AI tools for ophthalmology. Our innovation supports the therapy process, enabling doctors to make more informed decisions, thereby improving patient outcomes.
Unique AI-driven second opinion based on research which led to 3x better outcomes and kept almost 2x more patients in vision-preserving treatment
Focus on reducing therapy burden on clinicians and patients to improve treatment adherence.
Aim to boost therapy effectiveness and efficiency in response to the growing prevalence of retinal diseases worldwide.
Revolutionizing Clinical Studies with deepeye® Research
Discover the future of clinical studies with deepeye® Research, a cutting-edge AI platform transforming retinal therapy research. Our approach, honed through Europe's leading clinical methodologies, propels deepeye® to the forefront of innovation in anti-VEGF trials.
AI-Enhanced Research: Our platform empowers study teams across pharmaceuticals, medical devices, and payors, offering unparalleled insights and efficiency.
Advanced Analysis Capabilities: From supporting Phase IV studies to extracting new insights from Phase II-III data, our technology enables deeper understanding of OCT scans.
Comprehensive Data Management: Our system expertly handles diverse datasets, producing anonymized, standardized data and insightful AI reports for a complete research solution.
deepeye® Research is more than just a tool. It is a partnership in advancing precision medicine, enhancing clinical research, and shaping the future of need-based retinal therapy.